<DOC>
	<DOCNO>NCT00001495</DOCNO>
	<brief_summary>This study examine 96 hour infusion schedule irinotecan alternate 72 hour drug-free interval patient solid tumor order determine maximum tolerate dose regimen .</brief_summary>
	<brief_title>A Phase I Study Irinotecan ( CPT-11 ) Administered Prolonged Infusion Adult Patients With Solid Tumors</brief_title>
	<detailed_description>Irinotecan ( CPT-11 ) promise camptothecin analogue activity solid tumor . In Phase I study use short intravenous infusion schedule , predominant drug toxicity gastrointestinal , diarrhea , myelosuppression . In animal study , prolonged infusion schedule follow short drug-free interval result preservation antitumor activity decrease drug toxicity . Therefore , propose examine 96 hour infusion schedule irinotecan alternate 72 hour drug-free interval patient solid tumor order determine maximum tolerate dose regimen . The duration treatment escalate Phase I study patient receive therapy 2 every 3 week . Standard Phase I drug toxicity tumor response information monitor pharmacokinetics irinotecan active metabolite , SN-38 also examine . We also attempt monitor intracellular molecular effect SN-38 therapy blood , bone marrow , , whenever possible , tumor tissue .</detailed_description>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Recurrent metastatic cancer , include lymphoma . No leukemia . No active CNS disease . Refractory effective therapy OR No effective therapy exists . Measurable disease require . PRIOR/CONCURRENT THERAPY : Biologic Therapy : Greater 4 week recover immunotherapy . Chemotherapy : Greater 4 week recover chemotherapy . Previous therapy irinotecan permit . Endocrine Therapy : Not specify . Radiotherapy : Greater 4 week since radiotherapy . Surgery : Recovered prior surgery . PATIENT CHARACTERISTICS : Age : 18 . Performance status : ECOG 02 . Hematopoietic : AGC great 1,500 . Platelets great 100,000 . Hepatic : Bilirubin great 1.5 mg/dL . AST great 2 time normal . Renal : Creatinine great 1.5 mg/dL . OTHER : HIV negative . No active infection require antibiotic . No concurrent medical illness would interfere chemotherapy . No pregnant nursing woman . Adequate contraception require fertile patient . Imaging/exams tumor measurement within 28 day prior registration .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1999</verification_date>
	<keyword>Camptothecin</keyword>
	<keyword>Cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Natural Products</keyword>
	<keyword>Neoplasms</keyword>
</DOC>